シンポジウム

AMLにおけるMRD

2019年10月12日(土) 14:50 〜 17:00 第1会場 (東京国際フォーラム 4F ホールC)

座長：Shai Izraeli (Division of Pediatric Hematology and Oncology, Schneider Children's Medical Center of Israel, Israel), 宮本敏浩（九州大学大学院医学研究院病態修復内科）

+全てマイスケジュールに登録

[SY7-1] Measurable/residual disease (MRD) in AML. Recommendations from European LeukemiaNet with the role of flow cytometry in (stem cell) MRD and its relation to molecular approaches

Gerrit J. Schuurhuis, Jeroen JWM Janssen, Jacqueline Cloos (Department of Hematology, Amsterdam University Medical Center, Amsterdam, Netherlands)

[SY7-2] 急性骨髄性白血病における診断時や寛解時の遺伝子変異を用いた微小残存病変解析の重要性

山口博樹 (日本医科大学血液内科)

[SY7-3] Assessment of MRD in standard-risk AML

Robert K Hills¹, Sylvie Freeman², Richard Dillon³, Nigel Russell⁴, David Grimwade³ (1.University of Oxford, Nuffield Dept of Population Health, United Kingdom of Great Britain and Northern Ireland, 2.University of Birmingham, United Kingdom of Great Britain and Northern Ireland, 3.King's College, London, United Kingdom of Great Britain and Northern Ireland, 4.Nottingham University Hospitals, United Kingdom of Great Britain and Northern Ireland)

[SY7-4] 小児急性骨髄性白血病の微小残存病変のモニタリング

多賀崇 (滋賀医科大学小児科)